Grava Sergio, Braga Matheus, Souza Victor Hugo de, Pepineli Afonso Carrasco, Yamanaka Aléia Harumi Uchibaba, Ayo Christiane Maria, Zacarias Joana Maira Valentini, Simão Andréa Name Colado, Pinto Larissa Danielle Bahls, Neto Quirino Alves de Lima, Visentainer Jeane Eliete Laguila
Post-Graduation Program in Biosciences and Physiopathology, Department of Clinical Analysis and Biomedicine, State University of Maringá, Maringá 87020-900, PR, Brazil.
Laboratory of Immunogenetics, Department of Dermatological, Infectious and Parasitic Diseases, Faculty of Medicine of São José do Rio Preto, São José do Rio Preto 15090-000, SP, Brazil.
Int J Mol Sci. 2025 Jun 2;26(11):5341. doi: 10.3390/ijms26115341.
The high variability of human leukocyte antigen () genes results in each molecule having distinct antigenic peptide binding capacities, potentially influencing the immune response to SARS-CoV-2. This study aimed to investigate associations between (, ) and () polymorphisms and COVID-19 severity in a South Brazilian population, and to evaluate the binding affinity of alleles to viral peptides. A cross-sectional study included 503 unvaccinated patients with RT-qPCR-confirmed COVID-19: 145 non-severe, 129 severe, and 229 critical. typing was performed using PCR-SSO and Luminex™ technology. The allelic group was significantly associated with protection against severe and critical cases, while was associated with increased risk; both remained significant after Bonferroni correction. Other allelic groups were associated with disease outcomes but lost significance after correction: and (risk); and , , and (protection). In silico analysis revealed that the allele group showed a higher proportion of strong binders, mostly from non-structural proteins, while binders, though fewer in number, were concentrated in the M protein. These results suggest functional differences in antigen presentation and reinforce the relevance of , particularly , in modulating COVID-19 severity.
人类白细胞抗原(HLA)基因的高度变异性导致每个分子具有独特的抗原肽结合能力,这可能会影响对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的免疫反应。本研究旨在调查巴西南部人群中HLA(HLA-A、HLA-B)和HLA-DRB1多态性与冠状病毒病2019(COVID-19)严重程度之间的关联,并评估等位基因与病毒肽的结合亲和力。一项横断面研究纳入了503例经逆转录定量聚合酶链反应(RT-qPCR)确诊为COVID-19的未接种疫苗患者:145例非重症患者、129例重症患者和229例危重症患者。使用聚合酶链反应-序列特异性寡核苷酸探针(PCR-SSO)和Luminex™技术进行HLA分型。HLA-A等位基因组与预防重症和危重症病例显著相关,而HLA-B则与风险增加相关;在Bonferroni校正后,两者仍具有显著性。其他等位基因组与疾病转归相关,但在校正后失去显著性:HLA-A24:02和HLA-A30:01(风险);以及HLA-A02:01、HLA-A11:01和HLA-DRB1*13:02(保护)。计算机分析显示,HLA-A等位基因组显示出较高比例的强结合者,主要来自非结构蛋白,而HLA-B结合者虽然数量较少,但集中在M蛋白中。这些结果表明抗原呈递存在功能差异,并加强了HLA,特别是HLA-A在调节COVID-19严重程度方面的相关性。